Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

STRATA Skin Sciences (SSKN) Shares Outstanding (2016 - 2025)

STRATA Skin Sciences' Shares Outstanding history spans 15 years, with the latest figure at $5.9 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 41.16% to $5.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a 41.16% increase, with the full-year FY2025 number at $5.9 million, up 41.16% from a year prior.
  • Shares Outstanding hit $5.9 million in Q4 2025 for STRATA Skin Sciences, up from $5.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for SSKN hit a ceiling of $34.7 million in Q1 2022 and a floor of $3.5 million in Q4 2022.
  • Historically, Shares Outstanding has averaged $14.6 million across 5 years, with a median of $4.2 million in 2024.
  • Biggest five-year swings in Shares Outstanding: plummeted 89.95% in 2023 and later soared 41.16% in 2025.
  • Tracing SSKN's Shares Outstanding over 5 years: stood at $34.4 million in 2021, then crashed by 89.9% to $3.5 million in 2022, then grew by 0.97% to $3.5 million in 2023, then grew by 18.97% to $4.2 million in 2024, then soared by 41.16% to $5.9 million in 2025.
  • Business Quant data shows Shares Outstanding for SSKN at $5.9 million in Q4 2025, $5.3 million in Q3 2025, and $4.2 million in Q2 2025.